Search research articles
Contact Us
Filters
Showing results (11-20 of 32) with videos related to
Page
of 4
Sort By:
Journal of Cellular Biochemistry
|
January 13, 2015
Pyrosequencing for accurate imprinted allele expression analysis
Bing Yang, Nathan Damaschke, Tianyu Yao, et al.
American Journal of Clinical and Experimental Urology
|
July 18, 2024
The role of PSA kinetics in men with a negative MRI-targeted prostate biopsy
Marcelo P Bigarella, Arighno Das, Diana Garcia, et al.
The Journal of Urology
|
November 24, 2012
CpG island hypermethylation frequently silences FILIP1L isoform 2 expression in prostate cancer
Joshua Desotelle, Matthew Truong, Jonathan Ewald, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
September 25, 2008
Protein expression of matriptase and its cognate inhibitor HAI-1 in human prostate cancer: a tissue microarray and automated quantitative analysis
Miranda Warren, Matthew Twohig, Thomas Pier, et al.
American Journal of Clinical and Experimental Urology
|
September 22, 2025
Impact of commonly used medications on the detection of clinically significant prostate cancer in the targeted biopsy era
Krista N Brackman, Marcelo P Bigarella, Arighno Das, et al.
Plos One
|
April 16, 2015
Overexpression of the novel senescence marker β-galactosidase (GLB1) in prostate cancer predicts reduced PSA recurrence
Jennifer Wagner, Nathan Damaschke, Bing Yang, et al.
Plos One
|
June 25, 2019
Screening of urine identifies PLA2G16 as a field defect methylation biomarker for prostate cancer detection
William E Jarrard, Adam Schultz, Tyler Etheridge, et al.
American Journal of Clinical and Experimental Urology
|
March 27, 2020
Trends in epidural anesthesia use at the time of radical cystectomy and its association with perioperative and survival outcomes: a population-based analysis
Brady L Miller, E Jason Abel, Glenn Allen, et al.
BMC Cancer
|
December 22, 2017
Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomes
Shivashankar Damodaran, Nathan Damaschke, Joseph Gawdzik, et al.
Journal for Immunotherapy of Cancer
|
March 4, 2026
Androgen deprivation, androgen receptor-targeted vaccination, and nivolumab in patients with high-risk localized prostate cancer
David Jarrard, Jens Eickhoff, Christos E Kyriakopoulos, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 32) with videos related to
Sort By:
Page
of 4
Journal of Cellular Biochemistry
|
January 13, 2015
Pyrosequencing for accurate imprinted allele expression analysis
Bing Yang, Nathan Damaschke, Tianyu Yao, et al.
American Journal of Clinical and Experimental Urology
|
July 18, 2024
The role of PSA kinetics in men with a negative MRI-targeted prostate biopsy
Marcelo P Bigarella, Arighno Das, Diana Garcia, et al.
The Journal of Urology
|
November 24, 2012
CpG island hypermethylation frequently silences FILIP1L isoform 2 expression in prostate cancer
Joshua Desotelle, Matthew Truong, Jonathan Ewald, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
September 25, 2008
Protein expression of matriptase and its cognate inhibitor HAI-1 in human prostate cancer: a tissue microarray and automated quantitative analysis
Miranda Warren, Matthew Twohig, Thomas Pier, et al.
American Journal of Clinical and Experimental Urology
|
September 22, 2025
Impact of commonly used medications on the detection of clinically significant prostate cancer in the targeted biopsy era
Krista N Brackman, Marcelo P Bigarella, Arighno Das, et al.
Plos One
|
April 16, 2015
Overexpression of the novel senescence marker β-galactosidase (GLB1) in prostate cancer predicts reduced PSA recurrence
Jennifer Wagner, Nathan Damaschke, Bing Yang, et al.
Plos One
|
June 25, 2019
Screening of urine identifies PLA2G16 as a field defect methylation biomarker for prostate cancer detection
William E Jarrard, Adam Schultz, Tyler Etheridge, et al.
American Journal of Clinical and Experimental Urology
|
March 27, 2020
Trends in epidural anesthesia use at the time of radical cystectomy and its association with perioperative and survival outcomes: a population-based analysis
Brady L Miller, E Jason Abel, Glenn Allen, et al.
BMC Cancer
|
December 22, 2017
Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomes
Shivashankar Damodaran, Nathan Damaschke, Joseph Gawdzik, et al.
Journal for Immunotherapy of Cancer
|
March 4, 2026
Androgen deprivation, androgen receptor-targeted vaccination, and nivolumab in patients with high-risk localized prostate cancer
David Jarrard, Jens Eickhoff, Christos E Kyriakopoulos, et al.
Page
of 4